CRISP-Register

A randomized, double blind, placebo controlled study to assess the effects of Bempedoic Acid (ETC-1002) on the occurrence of major cardiovascular events in patients with, or at high risk for cardiovascular disease who are statin intolerant.

Weitere Informationen